Can existing unrelated vaccines boost a COVID-19 vaccine prime?

by Nathaniel Hupert, Daniela Marín-Hernández, Douglas F. Nixon
Published 2021-02-01

The geology of the Vakkerlien nickel prospect, Kvikne, Norway

by J.F.H. Thompson, F. Nixon, R. Sivertsen
Published 1980-06-01

Extreme immunotherapy: emergency immunology to defeat pandemics

by Douglas F. Nixon, Daniela Marín-Hernández, Nathaniel Hupert
Published 2021-09-01

Heterologous vaccine interventions: boosting immunity against future pandemics

by Daniela Marín-Hernández, Douglas F. Nixon, Nathaniel Hupert
Published 2021-05-01

Allatostatin C modulates nociception and immunity in Drosophila

by Nathaniel D. Bachtel, Gary A. Hovsepian, Douglas F. Nixon, Ioannis Eleftherianos
Published 2018-05-01

Expression of CircRNAs in HIV-1 latently infected cells from an in vitro model

by L. Iniguez, D.C. Copertino, Jr, D.F. Nixon, M. De Mulder Rougvie
Published 2019-12-01

TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction

by Robert L. Furler, Douglas F. Nixon, Christine A. Brantner, Anastas Popratiloff, Christel H. Uittenbogaart
Published 2018-06-01

Cardiopulmonary resuscitation skill training and retention in teens (CPR START): A randomized control trial in high school students

by Haamid Chamdawala, James A. Meltzer, Viswanathan Shankar, Dina Elachi, Shannon M. Jarzynka, Abigail F. Nixon
Published 2021-03-01

Genetic risk for severe COVID‐19 correlates with lower inflammatory marker levels in a SARS‐CoV‐2‐negative cohort

by Timothy R Powell, Matthew Hotopf, Stephani L Hatch, Gerome Breen, Rodrigo R R Duarte, Douglas F Nixon
Published 2021-01-01

Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target

by Gislaine Curty, Jez L. Marston, Miguel de Mulder Rougvie, Fabio E. Leal, Douglas F. Nixon, Marcelo A. Soares
Published 2020-07-01

Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.

by R Brad Jones, Keith E Garrison, Jessica C Wong, Erick H Duan, Douglas F Nixon, Mario A Ostrowski
Published 2008-01-01

Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.

by Emily M Eriksson, Chris E Keh, Steven G Deeks, Jeffrey N Martin, Frederick M Hecht, Douglas F Nixon
Published 2012-01-01

Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival

by Allison R. Kolbe, Matthew L. Bendall, Alexander T. Pearson, Doru Paul, Douglas F. Nixon, Marcos Pérez-Losada, Keith A. Crandall
Published 2020-08-01

MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.

by Dominic Paquin-Proulx, Benjamin C Greenspun, Emanuela A S Costa, Aluisio C Segurado, Esper G Kallas, Douglas F Nixon, Fabio E Leal
Published 2017-01-01

Enriched environment and stress exposure influence splenic B lymphocyte composition.

by Blake T Gurfein, Burcu Hasdemir, Jeffrey M Milush, Chadi Touma, Rupert Palme, Douglas F Nixon, Nicholas Darcel, Frederick M Hecht, Aditi Bhargava
Published 2017-01-01

Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).

by Karina I Carvalho, Karina M Melo, Fernanda R Bruno, Jennifer E Snyder-Cappione, Douglas F Nixon, Beatriz T Costa-Carvalho, Esper G Kallas
Published 2010-09-01

A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males.

by Jennifer E Snyder-Cappione, Camilla Tincati, Ijeoma G Eccles-James, Amedeo J Cappione, Lishomwa C Ndhlovu, Laura L Koth, Douglas F Nixon
Published 2010-11-01

Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.

by Brinda Emu, Walter J Moretto, Rebecca Hoh, Melissa Krone, Jeffrey N Martin, Douglas F Nixon, Steven G Deeks, Joseph M McCune
Published 2014-01-01

A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

by Karina M Melo, Karina I Carvalho, Fernanda R Bruno, Lishomwa C Ndhlovu, Wassim M Ballan, Douglas F Nixon, Esper G Kallas, Beatriz T Costa-Carvalho
Published 2009-07-01

Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans.

by Aashish R Jha, Douglas F Nixon, Michael G Rosenberg, Jeffrey N Martin, Steven G Deeks, Richard R Hudson, Keith E Garrison, Satish K Pillai
Published 2011-01-01